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Abstract  
Introduction: Basaloid squamous cell carcinoma is a rare aggressive malignancy that is a distinct 
variant of squamous cell carcinoma. Basaloid squamous cell carcinoma (BSCC) of the oral mucosa other 
than the tongue is uncommon. Its aggressive clinical behavior is characterized by a high incidence of 
local recurrence, regional lymph node metastases and mortality rate. Because of the advanced stage at 
presentation, oral BSCC is prognostically worse. 
Presentation of Case: We reported a case of 45 year-old women who presented with a painful, reddish 
and irregular mass on the left mandibular gingiva and was diagnosed as Stage IV BSCC on the gingiva.  
Conclusion: Patients with BSCC have advanced disease at presentation.  Accurate histopathologic 
distinction between the basaloid tumors is of considerable clinical importance. Survival rate of BSCC is 
less than poorly differentiated squamous cell carcinoma and should have separate treatment  protocol 
from that of conventional squamous cell carcinoma. 
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Introduction 
Worldwide, oral cancer accounts for 2%–4% of all cancer cases. In some regions the prevalence of oral cancer is 
higher reaching around 45% in developing country like India. In 2004-2009 over 300,000 new cases of oral and 
oropharyngeal cancer were diagnosed worldwide. During the same time period, over 7,000 affected individuals 
died of these cancers [1]. Most cancer in the head and neck is squamous cell carcinoma (HNSCC) and the 
majority is oral squamous cell carcinoma (OSCC). OSCC is probably the eighth most common cancer 
world-wide but parts of Northern France and East Europe, particularly Hungary, and parts of South America and 
South East Asia have particularly high prevalences. It is a disease found particularly in low income communities 
and is still mainly a problem of older people, 90% being in over 45 year age. Warnakulasuriya points out that 
OSCC remains a lethal disease for over 50% of cases diagnosed annually largely reflected by the fact most cases 
are in advanced stages at the time of detection despite easy accessibility for regular examination [2]. Percentages 
of morbidity and mortality in males are 6.6/100,000 and 3.1/100,000 respectively, while in females the same 
percentages are 2.9/100,000 and 1.4/100,000.
1
 Etiology and pathogenesis of basaloid cell carcinoma is similar to 
conventional squamous carcinoma. Most patients have a long history of smoking and alcohol drinking. In some 
cases there is a history of previous radiation to the head and neck region. Both represent independent risk factors 
for the development of squamous cell carcinoma. Smokeless tobacco and other exogenous carcinogens such as 
occupational, environmental and nutritional factors may also play role in the pathogenesis of this cancer. EBV 
was detected in few cases using in situ hybridization technique from nasopharyngeal sites. Recent studies 
detected a higher frequency of HPV and HSV in basaloid tumors than in conventional squamous cell carcinomas 
of the head and neck. Basaloid squamous cell carcinoma in non smoker young patients revealed infection with 
HPV, high risk genotype 16. The expression is so significant, to the extent that it led some authors to consider the 
expression may be important for the diagnosis of this type of squamous cell carcinoma [3].
 
In countries where the 
habit of betel-tobacco chewing is widespread, buccal mucosal involvement is more frequent. But, cancer of 
gingival and alveolar ridge are generally seen in the area of placement of the tobacco quid in those who practice 
this habit. Consequently the mandibular gingiva is more commonly involved than maxillary gingival [4]. Wain et 
al. [5] first proposed that basaloid squamous cell carcinoma (BSCC) was a distinct variant of squamous cell 
carcinoma (SCC). In 1991, the World Health Organization included this tumor in the revised classification for the 
upper respiratory tract and ear [6]. The most frequent sites of occurrence in the upper aerodigestive tract are the 
base of the tongue, the larynx and the pyriform sinus [7]. Ide et al.[8]
 
reported 46 cases of BSCC in the oral 
mucosa, with a single case of BSCC in the gingiva. It is generally accepted that head and neck BSCC tends to 
have an aggressive clinical course than stage-matched conventional SCC, with frequent local recurrences; and 
regional and distant metastases. Here, a case of BSCC arising in the gingiva is reported and the literature 
reviewed for establishing the clinicopathologic characteristics of oral BSCC. The differential diagnosis with other 
basaloid oral carcinomas should be made cautiously. 
Case report 
A 45-year-old women complained of swelling and pain in left mandibular gingiva. Patient was apparently alright 
before 1 month after which she noticed a small swelling on lower left posterior region of the gingiva. The 
swelling was initially small pea sized which rapidly increased to attain the present size. Patient also complains of 
diffuse, dull continuous pain in the same region which is radiating upto the neck, pre & post auricular region on 
same side since 10 – 15 days; and also complains of dysphagia. Pain is aggravated on eating food, mouth opening. 
Her medical history was noncontributory. Patient has the habit of tobacco and lime chewing 10-15 times a day 
since 20 years and keeps the mixture in the left buccal vestibule. Patient also applies mishri on gums and teeth 
4-5 times a day since 20 years. Extra oral examination revealed facial asymmetry due to diffuse, ill defined 
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swelling on left side of face which is firm in consistency and fixed to underlying structures; extending from 2cm 
posterior to angle of mandible upto 1 cm anterior to corner of mouth; and superiorly extending from 2cm below 
the zygomatic arch and inferiorly upto to submandibular region on left side & entire submental region (Figure 1). 
On palpation, the submandibular, pre and post auricular lymph nodes on left side; and submental lymph nodes 
were enlarged, tender, hard and fixed to underlying structures. Intra oral examination revealed ulceroproliferative 
growth which was reddish pink, irregular, 5 x 2 cm mass on left mandibular posterior buccal gingiva and 
obliterating the buccal vestibule in the region of 35 to 38 (Figure 2). On palpation the lesion was firm to hard in 
consistency and bleeds on provocation; the borders are indurated and lesion is fixed to underlying structures. 
There were no other oral mucosal anomalies. An incisional biopsy was performed and was reported as BSCC 
histopathologically. The lesion was staged as T3 N2b M0. The patient was referred to higher center for further 
treatment.  
                     
 
 
 
 
 
 
 
 
 
 
 
 
 
Gross specimen of the incisional biopsy from the region of 36 on macroscopic examination showed a circular 
mass of size approximately 2.2 X 2.1 X 1.8 cm, grayish white in color and firm in consistency. The outer surface 
was nodular whereas the undersurface was rough and irregular (figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Figure 2 
Figure 3 
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Figure 4.a) Surface epithelium showing dysplastic features involving entire thickness of epithelium (H and E, X40); 4.b) 
Infiltrating strands of tumor epithelial cells  in connective tissue (H and E, X40); 4.c) Islands showing peripheral palisading 
of basaloid cells (H and E, X40); 4.d) Tumor cells showing numerous mitotic figures (arrows, H and E, X40);  4.e) Tumor 
islands showing comedo‑like necrosis (H and E, X40); 4.f) Infiltrating strands of tumor epithelial cells showing keratin pearl 
formation (H and E, X10). 
 
Histopathologically, Haematoxylin and eosin stained tissue section showed (figure 4.a-4.f) surface epithelium 
4.e 
4.a 4.b 
4.c 
4.e 4.f 
4.d 
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which is absent at places and other areas shows dysplastic features involving the whole thickness of epithelium. 
The basement membrane is indistinct and discontinuous. The underlying connective tissue shows infiltration of 
dysplastic epithelial cells in the form of strands, cords, islands and sheets. The infiltrating cells shows dysplastic 
features like cellular and nuclear pleomorphism, increased nuclear cytoplasmic ratio, numerous abnormal mitotic 
figures, individual cell keratinization and keratin pearl formation. Numerous islands comprising of basaloid cells 
are evident. At places the islands contain densely packed basaloid cells whereas some areas show islands with 
central comedo necrosis and periphery of the island shows tall columnar cells with palisaded nuclei. The basaloid 
cells comprise of hyperchromatic nuclei and scanty cytoplasm. The epithelial islands are separated by loosely and 
haphazardly arranged bundles of collagen fibers, mild to moderate amount of chronic inflammatory cells like 
lymphocytes and plasma cells, numerous small blood capillaries are also seen. At places areas of extravasation 
are seen. Overall features were suggestive of Basaloid squamous cell carcinoma.  
Discussion 
BSCC is the designation initially introduced by Wain et al. in 1986. Since then, the incidence of this tumor is 
constantly increasing. As early as 1927, Quick and Cutler
  
mentioned the existence of undifferentiated SCC of 
the nasopharynx, tonsil and tongue base where BSCC occurs more frequently, but they provided no 
histopathologic details other than this type of tumor is highly malignant and radiosensitive. They recommended 
the name ‘‘transitional cell epidermoid carcinoma’’. According to Ferlito et al., 158 cases have been identified in 
the literature. Similar, if not identical, tumours have been reported in a wide variety of non head and neck sites [9].
 
Basaloid squamous cell carcinoma is a rare high grade variant of SCC [10].
  
In the head and neck, it occurs most 
commonly in the pyriform sinus, larynx, and base of the tongue [7]. Overall clinical findings of oral BSCC are 
essentially similar to previously reported results in other anatomic sites. Interestingly, although more than 80% of 
head and neck BSCC affected males, oral tumors occurred almost equally in both sexes. Greater number of 
patients with oral BSCC will be needed to explain this discrepancy. Like the conventional SCC, tobacco use and 
alcohol consumption appear to represent risk factors. Epstein–Barr virus or human papilloma virus may play a 
role in the development of site specific nasopharyngeal and genital or anal canal BSCCs, but Ide et al. [8], did not 
find evidence of viral infection in their two cases of oral BSCC. BSCC of the oral mucosa is rare. The histologic 
features of BSCC have been described in many reports [5,7,8,11]. The neoplasm is composed chiefly of basaloid 
cells with the typical finding of foci of squamous differentiation and the basaloid cells have dark hyperchromatic 
nuclei and a scant cytoplasm. The neoplasm has squamous differentiation ranging from focal squamous 
differentiation to Carcinoma in situ (CIS) to invasive SCC. The neoplasm occasionally shows palisading of the 
peripheral tumor cells, comedonecrosis, and intratumoral cystic spaces. To confirm the epithelial differentiation, 
earlier investigators used AE1/AE3 stains, although the percentage of positivity varies greatly among different 
reports [7,10,12,13].
 
 
Clinical features of 41 cases of oral BSCC are summarized in Table 1. Oral BSCC has the following 
characteristics:  
(1) a strong predilection for the base of tongue;  
(2) an occurrence in an older population with a mean age of 61 years;  
(3) male predominance;  
(4) an advanced clinical Stage III or IV presentation;  
(5) an aggressive clinical course characterized by a high incidence of cervical lymph node metastases at the initial 
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presentation;  
(6) local recurrence;  
(7) subsequent lymph node metastases and  
(8) death from disease.  
These results indicate that the tendency for oral BSCC to present with disease of more advanced stage may be 
attributed in part to the poor prognosis. Because of the limited number of cases, divided among five anatomical 
locations in the oral mucosa, no meaningful data are available for therapeutic approaches in each specific site. In 
41 cases, 38 patients were treated surgically, 21 of who received radiation therapy, 9 received adjuvant 
chemotherapy and eight   patients had a combination of irradiation and chemotherapy and 3 patients did not 
undergo any treatment. According to Ide et al. [8], few cases of BSCC in the oral mucosa have been reported in 
the English-language literature, with a single case of BSCC in the gingiva. Later Eiji Hirani et al. [14], in 2009 
published a review on 6 cases of BSCC occurring in gingiva. The present case adds 1 more case of BSCC 
occurring in gingiva, making the number to 8. 
 
 
Table 1 Summary of clinical characteristics of oral  BSCC.
8
 
Number of affected sites,n= 53 Tongue  28 
 Palate 3 
 Buccal mucosa 1 
 Gingiva 8 
Gender (n= 41) Mal e 23 
 Female 18 
Age (n= 41) Range  39-83 years 
 Average  61 years 
Stage (n=41) I 8 
 II 10 
 III 10 
 IV 13 
No metastasis  16 
Metastasis (n= 25) Local nodal metastasis 18 
No treatment  3 
Treatment (n=38) Surgery 38 
 Radiation 21 
 Chemotherapy 9 
 Radiation & Chemotherapy 8 
Local recurrence  8 
Outcome (n=41) Distant metastasis 7 
 Died of disease 15 
 Alive with disease 4 
 Alive without disease 18 
 Not known 4 
 
The differential diagnosis of BSCC includes adenoid cystic carcinoma (ACC), small cell undifferentiated 
carcinoma, basal cell adenocarcinoma (BCAC), adenosquamous carcinoma, and basosquamous carcinoma 
[8,15].Both the cytologic and histomorphologic characteristics of the solid type of ACC are quite similar to those 
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of BSCC. Klijanienko et al. indicated that distinguishing between BSCC and ACC may be difficult or impossible, 
especially when only a small diagnostic biopsy sample is available. Although one paper stated that 
immunohistochemistry was not particularly helpful in distinguishing between ACC and BSCC [16], several 
authors found that immunohistochemistry was helpful in distinguishing between the two [15,17]. Coletta et al. 
[15] found that the cells of ACC expressed CK7, signaling a ductal pattern possibly of salivary gland origin, 
whereas the basaloid cells in BSCC were positive only for CK14. Furthermore, the presence of basement 
membrane–like material positive for laminin and type IV collagen in the microcystic spaces is a feature of BSCC 
but not of ACC. Madur et al.[17]
 
found that BSCC were negative for vimentin and S-100. Emanuel et al. found 
that the p63 staining pattern of BSCC differed strikingly from the staining pattern in ACC. BSCC consistently 
displayed diffuse p63 positively, with staining of nearly 100% of tumor cells. In contrast, ACC displayed a 
consistently compartmentalized pattern within tumor nests. Andreadis et al. found that BSCC and BCAC shared 
some similar microscopic features, such as basaloid epithelial cell aggregations in solid, membranous, trabecular, 
and tubular nests separated from each other by thin septa or thick bands of collagenous stroma, a characteristic 
peripheral palisading of nuclei, foci of necrosis and stromal hyalinization; and immunohistchemical findings are 
critically helpful in the differential diagnosis of these tumors. Immunohistochemically, CK7, vimentin, and S100 
are positive in BCAC but not in BSCC. Cadier et al.
 
stated that it was worthwhile to note that basaloid squamous 
carcinoma is quite distinct from basosquamous carcinoma, which is an atypical basal cell carcinoma of the skin, 
has squamous elements, is an aggressive tumor, and not uncommonly metastasizes, unlike normal basal cell 
carcinoma. The clinical course and prognosis of BSCC are thought to be worse than those of typical SCC, based 
on the high recurrence rates, regional and distant metastases, and lower survival rates [7,11]. However, few 
studies have evaluated the clinical course of BSCC located exclusively within the mouth, and the sample sizes are 
too small to be representative or to determine a prognosis [15]. Sampaio Goes et al. compared 17 BSCCs in the 
oral cavity with typical SCCs in the oral cavity and concluded that the prognosis of BSCC does not differ from 
that of typical SCC when matched for clinical stage. We could find English-language literature summarizing 
BSCC in the gingival and we summarized the reported cases, including the present case. Unfortunately, the 
sample size is too small to establish prognosis. 
 
HISTOPATHOLOGICAL DIFFERENTIAL DIAGNOSIS
18 
 
 Basal cell ameloblastoma 
 Adenoid cystic carcinoma (solid variant) 
 Adenosquamous carcinoma 
 Basal cell adenocarcinoma 
 Salivary duct carcinoma 
 Small cell undifferentiated carcinoma 
 
According to the various studies performed in the literature, IHC analysis for BSCC showed different cellular 
components expressing different markers as shown in the Table 2 [15,19]: 
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Conclusion 
Accurate histopathologic distinction between the basaloid tumors is of considerable clinical importance. Since the 
full extent of BSCC may not be evident in small or superficial biopsy, it is critical that the specimen includes the 
interface of tumor with surrounding tissue and surface epithelium. BSCC have advanced disease at presentation. 
Metastasis occurred in 52% cases of BSCC and 13% cases of poorly differentiated squamous cell carcinoma. 
Survival rate of BSCC is less than half of poorly differentiated squamous cell carcinoma. BSCC should have 
separate (exceptionally aggressive) treatment protocol from that of conventional SCC [9].
 
 
Table 2 Immunohistochemical analysis for BSCC 
 
Cell type  IHC marker  
SQUAMOUS DIFFERENTIATION   CK 13+ve areas seen in Basaloid areas.  
 CK 1 +ve  
 CEA +ve  
BASALOID CELLS  CK 13 -ve  
 CK 14 +ve (less reactive)  
 CK 903 (less reactive)  
 p53, p63, Ki 67 +ve  
MICROCYSTIC  SPACES  Anti- laminin antibody +ve  
 Type IV collagen +ve  
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